SueWallSt

#098 $PMI Picard Medical Artificial Heart or Artificial Hype

In this episode of Sue Wall Street Holding Wall Street Accountable, we examine the securities class action involving $PMI Picard Medical and its low float IPO, extreme stock volatility, and alleged social media stock promotion scheme. We break down the four dollar IPO, the rapid surge above thirteen dollars, the seventy percent collapse, WhatsApp trading groups, micro cap manipulation risks, and Rule 10b5 claims. This deep dive is for retail investors, IPO traders, and anyone following stock market news, pump and dump allegations, and securities litigation.
Visit ZLK.com for more info.
Add our WhatsApp Channel.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#097 $RR Richtech Robotics AI Collaboration or Market Manipulation

In this episode of Sue Wall Street Holding Wall Street Accountable, we break down the securities class action involving $RR Richtech Robotics and its headline making Microsoft AI collaboration. We analyze the press release language, the forty four percent stock surge, the thirty eight million dollar private placement, Microsoft’s denial of a commercial partnership, and the sharp stock drop that followed. This deep dive is for retail investors, tech stock traders, and anyone following AI investing, small cap stocks, and securities litigation news.
Visit ZLK.com for more info.
Add our WhatsApp Channel
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#096 $METC Ramaco Resources Rock Solid Opportunity or Potemkin Mine

In this episode of Sue Wall Street Holding Wall Street Accountable, we investigate the securities class action surrounding $METC Ramaco Resources and its rare earth minerals pivot at the Brook Mine. We break down the ribbon cutting event, alleged lack of mining activity, drone footage claims, SEC filings, stock drop, and Rule 10b5 allegations. This deep dive is for retail investors, traders, and anyone following stock market news, mining stocks, rare earth investing, and securities litigation.
Visit ZLK.com for more info.
Add our WhatsApp Channel
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#095 $BYND Beyond Meat Sizzles or Burns Investors

In this episode of Sue Wall Street Holding Wall Street Accountable, we break down the securities class action surrounding $BYND Beyond Meat and its alleged asset impairment and disclosure issues. We explore EBITDA goals, non cash impairment charges, SEC filings, stock drops, and what it all means for shareholders. This deep dive is for retail investors, traders, and anyone interested in stock market news, securities litigation, and corporate transparency.
Visit ZLK.com for more info.
Add our WhatsApp Channel
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#094 $BRBR Shakes and Red Flags What BellRing Didn’t Tell Investors

In this episode of Sue Wall Street Holding Wall Street Accountable we break down the explosive class action lawsuit against BellRing Brands Inc $BRBR the company behind Premier Protein. This podcast is for investors shareholders and anyone curious about stock market lawsuits securities fraud and corporate accountability. We dive deep into alleged misrepresentations inventory stockpiling hidden demand issues and competitive pressures with clear explanations real world context and a bit of sharp commentary.
Expect an investigative deep dive with analysis and plain English breakdowns designed to help retail investors stay informed and alert.
Visit ZLK.com for more info.
Add our WhatsApp Channel.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#093 Smoked by Smart Digital: The $SDM Social Media Pump-and-Dump

$SDM Smart Digital Group rocketed from $4 to nearly $30 per share then crashed over 85% amid allegations of a massive market manipulation scheme. In this episode of Sue Wall Street: Holding Wall Street Accountable, we expose how fake advisors, WhatsApp hype, and crypto buzz drove a meteoric rise… and a brutal collapse. If you're into IPO scams, SEC drama, and investor deception this one’s for you.
Visit ZLK.com for more info.
Add our WhatsApp Channel.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#092 Mist Opportunity: The $VTGN Drug Trial That Vaporized Millions

$VTGN Vistagen Therapeutics hyped its anxiety drug fasedienol as a game-changer but when the Phase 3 trial failed, the stock plummeted 80% in one day. In this episode of Sue Wall Street: Holding Wall Street Accountable, we break down the lawsuit accusing $VTGN of misleading investors with overly optimistic projections while hiding known risks tied to flawed trial design. If you're into biotech drama, trial data spin, and sudden stock collapses don’t miss it.
Visit ZLK.com for more info.
Add our WhatsApp Channel.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#091 Concrete Delays and Cloudy Claims: The $CRWV Collapse

$CRWV CoreWeave rocketed 349% after its IPO, fueled by AI hype and a $11.9B OpenAI deal. But when delayed data centers, rainy Texas weather, and missed guidance hit, the stock cratered and now they’re facing a class action lawsuit. In this episode of Sue Wall Street: Holding Wall Street Accountable, we unpack the allegations of securities fraud, infrastructure failure, and inflated projections that have investors crying foul.
Visit ZLK.com for more info.
Add our WhatsApp Channel.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#090 Scent of a Sell-Off: The $BBWI Strategy That Backfired

$BBWI Bath & Body Works touted its bold pivot "adjacencies, collaborations, and promotions" as the key to growth. But a class action lawsuit now claims that strategy masked core business struggles, ultimately leading to a 25% stock drop. In this episode of Sue Wall Street: Holding Wall Street Accountable, we dive into what investors were told, what was allegedly left out, and why this fragrance-forward brand is now fighting legal fires.
Visit ZLK.com for more info.
Add our WhatsApp Channel.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.

#089 Flatlining Finances: The $ARDT IPO That Misdiagnosed Itself

$ARDT Ardent Health pitched precision and transparency in its IPO but behind the scenes, it was relying on a flawed accounting method that allegedly overstated revenue by $43M and masked malpractice risks with underfunded reserves. In this episode of Sue Wall Street: Holding Wall Street Accountable, we examine the class action accusing $ARDT of inflating its value with outdated assumptions and misleading disclosures. If you care about healthcare, Wall Street truth, and IPO red flags don’t miss this one.
Visit ZLK.com for more info.
Add our WhatsApp Channel.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.